134 related articles for article (PubMed ID: 1538184)
1. Positron emission tomography and its role in the evaluation of brain tumors.
Chin HW; Eisenberg RL
J La State Med Soc; 1992 Jan; 144(1):25-7. PubMed ID: 1538184
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
3. A technique utilizing positron emission tomography and magnetic resonance/computed tomography image fusion to aid in surgical navigation and tumor volume determination.
Kraus GE; Bernstein TW; Satter M; Ezzeddine B; Hwang DR; Mantil J
J Image Guid Surg; 1995; 1(6):300-7. PubMed ID: 9080351
[TBL] [Abstract][Full Text] [Related]
4. PET, CT, and MRI in the evaluation of neuropsychiatric disorders: current applications.
Jolles PR; Chapman PR; Alavi A
J Nucl Med; 1989 Oct; 30(10):1589-606. PubMed ID: 2677265
[TBL] [Abstract][Full Text] [Related]
5. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
6. New imaging modalities: positron emission tomography and nuclear magnetic resonance.
Rollo FD
Med Instrum; 1982; 16(1):53-4. PubMed ID: 6977695
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
8. Brain tumors in children. I. Advances in diagnosis.
Finlay JL; Goins SC
Am J Pediatr Hematol Oncol; 1987; 9(3):246-55. PubMed ID: 3314549
[TBL] [Abstract][Full Text] [Related]
9. [The role of advanced cardiac imaging methods in coronary artery disease].
Kiraç S
Anadolu Kardiyol Derg; 2008 Jul; 8 Suppl 1():1-4. PubMed ID: 18611832
[TBL] [Abstract][Full Text] [Related]
10. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
Kinahan PE; Hasegawa BH; Beyer T
Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
[TBL] [Abstract][Full Text] [Related]
11. [Pathophysiology of dementia and medical imaging].
Yonekura Y
Rinsho Hoshasen; 1989 Oct; 34(11):1349-53. PubMed ID: 2601097
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
Bruschini P; Giorgetti A; Bruschini L; Nacci A; Volterrani D; Cosottini M; Ursino F; Mariani G; Fattori B
Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):446-53. PubMed ID: 15198047
[TBL] [Abstract][Full Text] [Related]
15. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography.
Tovi M; Lilja A; Bergström M; Ericsson A; Bergström K; Hartman M
Acta Radiol; 1990 Sep; 31(5):417-29. PubMed ID: 2261284
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
17. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions.
Lilja A; Lundqvist H; Olsson Y; Spännare B; Gullberg P; Långström B
Acta Radiol; 1989; 30(2):121-8. PubMed ID: 2493795
[TBL] [Abstract][Full Text] [Related]
19. [Neuroimaging in movement disorders--CT, MRI, and PET study].
Kobayashi O; Sakuragawa N
Nihon Rinsho; 1993 Nov; 51(11):2891-6. PubMed ID: 8277567
[TBL] [Abstract][Full Text] [Related]
20. Specification and selection of regions of interest (ROIs) in a computerized brain atlas.
Bohm C; Greitz T; Seitz R; Eriksson L
J Cereb Blood Flow Metab; 1991 Mar; 11(2):A64-8. PubMed ID: 1997490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
